TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PolyPeptide Laboratories (Sweden) AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
716,186
|
602,295
|
710,545 |
Financial expenses |
15,768
|
2,458
|
2,384 |
Earnings before taxes |
130,232
|
200,225
|
296,601 |
EBITDA |
173,814
|
186,164
|
304,584 |
Total assets |
1,337,538
|
1,013,741
|
1,044,021 |
Current assets |
890,108
|
598,277
|
715,506 |
Current liabilities |
280,221
|
210,352
|
246,287 |
Equity capital |
751,874
|
699,293
|
709,046 |
- share capital |
7,724
|
7,685
|
8,362 |
Employees (average) |
312
|
325
|
297 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.2%
|
69.0%
|
67.9% |
Turnover per employee |
2,295
|
1,853
|
2,392 |
Profit as a percentage of turnover |
18.2%
|
33.2%
|
41.7% |
Return on assets (ROA) |
10.9%
|
20.0%
|
28.6% |
Current ratio |
317.6%
|
284.4%
|
290.5% |
Return on equity (ROE) |
17.3%
|
28.6%
|
41.8% |
Change turnover |
110,789
|
-50,696
|
178,263 |
Change turnover % |
18%
|
-8%
|
33% |
Chg. No. of employees |
-13
|
28
|
31 |
Chg. No. of employees % |
-4%
|
9%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.